טוען...
Plasma acylated and plasma unacylated ghrelin: useful new biomarkers in patients with neuroendocrine tumors?
To date, the value of fasting plasma acylated ghrelin (AG) and unacylated ghrelin (UAG) as potential novel biomarkers in patients with neuroendocrine tumors (NETs) is unknown. The aims of this study are to (i) compare fasting AG and UAG levels between nonobese, nondiabetic NET patients (N=28) and ag...
שמור ב:
| הוצא לאור ב: | Endocr Connect |
|---|---|
| Main Authors: | , , , , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Bioscientifica Ltd
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5002960/ https://ncbi.nlm.nih.gov/pubmed/27215920 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1530/EC-16-0021 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|